Finerenone, polypharmacy, and clinical outcomes in heart failure: pre-specified analysis from the FINEARTS-HF trial.

Hamatani Y, Claggett BL, Kulac IJ, Desai AS, Jhund PS, Henderson AD, Lam CSP, Senni M, Shah SJ, Voors AA, Zannad F, Pitt B, Lage A, Sundaram J, De Sanctis Y, Glasauer A, McMurray JJV, Solomon SD, Vaduganathan M

Open source

DOI: 10.1093/ejhf/xuag030
Published: 2026 May 11
Container: European journal of heart failure
Publisher: Not recorded
Open access: unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1093/ejhf/xuag030,
  title = {Finerenone, polypharmacy, and clinical outcomes in heart failure: pre-specified analysis from the FINEARTS-HF trial.},
  author = {Hamatani Y and Claggett BL and Kulac IJ and Desai AS and Jhund PS and Henderson AD and Lam CSP and Senni M and Shah SJ and Voors AA and Zannad F and Pitt B and Lage A and Sundaram J and De Sanctis Y and Glasauer A and McMurray JJV and Solomon SD and Vaduganathan M},
  year = {2026},
  journal = {European journal of heart failure},
  doi = {10.1093/ejhf/xuag030},
  url = {https://doi.org/10.1093/ejhf/xuag030}
}

RIS

TY  - JOUR
TI  - Finerenone, polypharmacy, and clinical outcomes in heart failure: pre-specified analysis from the FINEARTS-HF trial.
AU  - Hamatani Y
AU  - Claggett BL
AU  - Kulac IJ
AU  - Desai AS
AU  - Jhund PS
AU  - Henderson AD
AU  - Lam CSP
AU  - Senni M
AU  - Shah SJ
AU  - Voors AA
AU  - Zannad F
AU  - Pitt B
AU  - Lage A
AU  - Sundaram J
AU  - De Sanctis Y
AU  - Glasauer A
AU  - McMurray JJV
AU  - Solomon SD
AU  - Vaduganathan M
PY  - 2026
JO  - European journal of heart failure
DO  - 10.1093/ejhf/xuag030
UR  - https://doi.org/10.1093/ejhf/xuag030
ER  -

APA

Y, H., BL, C., IJ, K., AS, D., PS, J., AD, H., CSP, L., M, S., SJ, S., AA, V., F, Z., B, P., A, L., J, S., Y, D. S., A, G., JJV, M., SD, S., & M, V. (2026). Finerenone, polypharmacy, and clinical outcomes in heart failure: pre-specified analysis from the FINEARTS-HF trial.. European journal of heart failure. https://doi.org/10.1093/ejhf/xuag030

Source records

pubmed · retrieved 2026-09-25T20:05:56.198Z